NYU Langone calls MS drug study ‘practice changing’ before results even published
Announcement on a new ‘pathway’ for multiple sclerosis treatment doesn’t lead far
‘Breakthrough’ in multiple sclerosis diagnostic? Not so fast.
UCSF offers cautious recap but equates surrogate markers with clinical outcomes in MS drug study
Claims but no context in summary of resistance training as a treatment for multiple sclerosis